My Gene Counsel
  • Biotechnology
  • Clinical Care Systems
  • Precision Medicine Partners
  • Solutions
    • Family History & Assessment
    • Living Lab Reports
    • Long-Term Notifications
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
Which of Your Patients Should Be Offered Genetic Testing for Cancer Risk in 2019?

Which of Your Patients Should Be Offered Genetic Testing for Cancer Risk in 2019?

by Danielle Bonadies | Mar 13, 2019 | Multimedia

Angelina Jolie’s Op-Ed Sparks Wider Discussion About Hereditary Cancer

by Danielle Bonadies | Mar 26, 2015 | Genetic Journal

Following Angelina Jolie Pitt’s disclosure earlier this week that she recently underwent a prophylactic bilateral salpingo-oophorectomy, we held an impromptu Tweet chat to discuss hereditary cancer and risk management. The BRCA community has...
< Prev12

Recent Posts

  • Genetic Counselors in the C-Suite
  • Oncology Insights: The Speed and Scope of Genetic Updates Expanding Genetic Testing to Advance Precision Medicine
  • My Gene Counsel and FamGenix Announce Strategic Partnership to Transform Genetic Risk Assessment and Patient Education
  • Genetic Counseling Toolkit For Students
  • 2024 STEM Gift Guide

Archives

  • About Us
  • One-Stop Solution
  • Living Lab Reports®
  • Media
  • Genetic Journal Blog
  • Career Resources
  • Population Studies
  • Healthcare Systems
  • Precision Medicine Partners
  • Contact Us
  • FAQs
  • Privacy Policy

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©